Skip to main content

Vir Biotechnology

Vir Biotechnology Inc is a clinical-stage immunology and biopharmaceutical enterprise headquartered in San Francisco, California. The company focuses on the development of novel immunotherapies for the treatment and prevention of infectious diseases, including hepatitis B, influenza, and HIV. Its research pipeline leverages proprietary technology to identify and develop therapeutic agents that harness the immune system. Principal revenue is currently earned through strategic partnerships, research grants, and capital financing arrangements as clinical candidates progress through development. Vir Biotechnology Inc is publicly listed on the Nasdaq Stock Market.

3 of the funds FundTelligence covers report a position in Vir Biotechnology.

Legal name
VIR BIOTECHNOLOGY
Sector
Health Care
Country
United States
Funds holding it
3

Funds holding Vir Biotechnology

Loading...